Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Galectin Therapeutic (GALT)

1.78 -0.06 (-3.26%)

8/17/2017  4:00pm

Open:

1.82

Pre. Close:

1.84

High:

1.86

Low:

1.74

Volume:

94,125

Market Cap:

62.39M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.92 - 1.95

1.95 - 2.01

Low:

1.63 - 1.66

1.66 - 1.71

Close:

1.72 - 1.79

1.79 - 1.88

Technical analysis  (as of: 2017-08-17 4:37:46 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 2.44     One year: 2.86

Support:

Support1: 1.51    Support2: 1.26

Resistance:

Resistance1: 2.09    Resistance2: 2.45

Pivot:

1.91

Moving Averages:

MA(5): 1.80     MA(20): 1.96

MA(100): 2.46     MA(250): 1.76

MACD:

MACD(12,26): -0.13     Signal(12,26,9): -0.13

%K %D:

%K(14,3): 40.54     %D(3): 36.50

RSI:

RSI(14): 38.71

52-Week:

High: 3.68  Low: 0.49  Change(%): -11.0

Average Vol(K):

3-Month: 13937  10-Days 11280

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
GALT has closed above bottom band by 25.3%. Bollinger Bands are 21% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 22 May 2017 21:11:15 GMT
Galectin Therapeutics: 1 More Shot To Get It Right?

Tue, 23 May 2017 13:41:15 GMT
Galectin Therapeutics: Serendipity In Psoriasis, Strength In NASH

Tue, 06 Jun 2017 12:32:39 GMT
Autoimmune Disease Patent Granted to Galectin Therapeutics

Fri, 23 Sep 2016 15:33:02 GMT
A Major Catalyst Awaits Galectin Therapeutics Next Week

Mon, 14 Aug 2017 12:11:15 GMT
Galectin Therapeutics Reports 2017 Second Quarter Financial Results and ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

34.67

Shares Float (M)

30.58

% Held by Insiders

21.14

% Held by Institutions

14.90

Shares Short (K)

1750

Shares Short Prior Month (K)

1360

Stock Financials

EPS

-0.670

EPS Est. Current Year

-0.560

EPS Est. Next Year

-0.790

EPS Est. Next Quarter

-0.150

Forward EPS

-0.790

Book Value (p.s.)

0.020

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-69.6

Return on Equity (ttm)

-134.2

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.591

Qtrly Earnings Growth

Operating Cash Flow (M)

-16.78

Levered Free Cash Flow (M)

-10.02

FoxReading.com

Valuation

P/E

-2.66

P/E Growth Ratio

-0.03

P/BV

89.00

P/S

P/CF

-3.68

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2012-03-23

Last Split Ratio

0.17

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.